Balaji Prasad

Healthcare

Limited coverage. Only 4 questions of coverage. Treat these numbers as directional — sample too small for reliable averages.

2

Companies

4

Questions

0%

Challenge RatePercentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions.

Focus Areas4 topics

Guidance Reliability2Revenue Growth2Regulation Policy1Innovation & R&D1

Question History4 questions

VTRSViatris1 quarter

2024 Q4

what would the focus of the Investor Day be? Is it more of incremental updates or are you envisaging a strategic shift

Guidance ReliabilityView in transcript →

Is there any commitment from the FDA on the timelines for reinspection in terms of service level

Regulation PolicyView in transcript →

ZTSZoetis1 quarter

2024 Q4

is there any way to quantify the approval though in the second bucket in the 12 to 36 months, what the TAM for these approvals are

Innovation & R&DRevenue GrowthView in transcript →

Curious to understand, maybe excluding FX, what are the upside risk to guidance that you can see from here?

Guidance ReliabilityRevenue GrowthView in transcript →